Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alfred Ogden

Neurological Surgery New York, NY Medical Doctor

NPI 1174795116 CMS profile 234556

710 W 168Th St, 5Th Floor, New York, NY 10032

Open in the dashboard

General payments

$39,240

61 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$2,210,370

11 holdings reported · through program year 2025

Through program year 2025, Alfred Ogden of New York, NY is reported in the CMS Open Payments database as having received $39,240 across 61 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $2,210,370 across 11 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,721 9
2024 General $1,154 6
2023 General $2,884 14
2022 General $7,095 12
2021 General $14,447 9
2020 General $5,022 2
2019 General $916 9
2025 Ownership $79,249 1
2024 Ownership $501,081 2
2023 Ownership $496,781 2
2022 Ownership $437,207 2
2021 Ownership $348,026 2
2020 Ownership $348,026 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alfred Ogden
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Alfred Ogden were reported at $7,721. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Alfred Ogden Neurological Surgery median Middle half National median
2019 $916 $582 $138–$3,006 $163
2020 $5,022 $294 $76–$2,174 $114
2021 $14,447 $387 $105–$2,432 $132
2022 $7,095 $542 $139–$2,989 $149
2023 $2,884 $534 $145–$2,697 $160
2024 $1,154 $574 $155–$3,046 $164
2025 $7,721 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Viseon, Inc. $23,930 20 payments
  2. Zavation LLC $7,500 6 payments
  3. NuVasive, Inc. $5,643 9 payments
  4. Medical Device Business Services, Inc. $560 4 payments
  5. Medtronic, Inc. $434 3 payments
  6. DePuy Synthes Sales Inc. $322 3 payments
  7. Alphatec Spine, Inc $155 2 payments
  8. Providence Medical Technology, Inc. $139 3 payments
  9. Nevro Corp. $107 1 payment
  10. Globus Medical, Inc. $104 1 payment
  11. Other $346 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $23,225 8 payments
  2. Current or prospective ownership or investment interest $9,235 2 payments
  3. Travel and Lodging $3,609 8 payments
  4. Food and Beverage $2,851 42 payments
  5. Education $320 1 payment
Products named General payments · program years 2019–2025
  1. MaxView System $14,316 6 payments
  2. Voyant System $5,022 2 payments
  3. X-CORE $5,000 1 payment
  4. MaxView System - Lateral Set $4,592 12 payments
  5. SYMPHONY $560 4 payments
  6. PRESTIGE LP CERVICAL DISC SYSTEM $320 1 payment
  7. ACP $282 2 payments
  8. XLIF $216 4 payments
  9. MaXcess $118 1 payment
  10. Senza $107 1 payment
  11. Other $708 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$69,867

Medicare's payments for the services billed

Medicare patients

162

Average age 74

Services billed

266

81 women, 81 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Ischemic heart disease 34%
Diabetes 31%
Osteoporosis 25%
Depression 20%
Chronic kidney disease 14%
Cancer 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

61 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record